Transcription of the Listeria monocytogenes positive regulatory factor A protein (PrfA) is initiated from either of two promoters immediately upstream of prfA (prfAp 1 and prfAp 2 ) or from the upstream plcA promoter. We demonstrate that prfAp 2 is a functional B -dependent promoter and that a sigB deletion mutation affects the virulence phenotype of L. monocytogenes. Thus, the alternative sigma factor B contributes to virulence in L. monocytogenes.
Bacterial survival within a host and establishment of infection depend in part on the ability of pathogenic bacteria to modulate gene expression in response to environmental conditions encountered during infection. Associations between alternative sigma factors and core RNA polymerase provide one mechanism for timely alterations in gene expression by directing transcription of different regulons in response to cellular signals (17) . Alternative sigma factors have been demonstrated to contribute to cellular survival under adverse conditions. For example, the stress-responsive alternative sigma factor B contributes to the ability of stationary-phase Listeria monocytogenes cells to adapt to and resume growth at reduced temperatures (3) .
B also has been shown to contribute to L. monocytogenes survival under in vitro conditions of oxidative stress, starvation, and reduced pH (9) . In addition to its presence in L. monocytogenes, B has been identified in diverse gram-positive organisms, including Listeria innocua, Staphylococcus aureus, Bacillus subtilis, Bacillus anthracis, Bacillus licheniformis, and Staphylococcus epidermidis (2, 5, 10, 13, 14, 15, 18, 23, 24) . Preliminary evidence suggests that B may contribute to virulence in gram-positive pathogens (8, 10, 15, 16, 23) . We hypothesize that bacterial virulence capabilities are linked with environmental stress responses mediated by alternative sigma factors and thus propose that stress-responsive alternative sigma factors (and specifically B ) contribute to the ability of L. monocytogenes to cause disease. In this report, we demonstrate that B contributes to regulation of L. monocytogenes virulence gene expression and that loss of B function impairs L. monocytogenes virulence in a murine model.
Loss of B impairs L. monocytogenes virulence in a murine model. In previous work, we found modest effects of a ⌬sigB mutation on L. monocytogenes virulence in the murine model. Specifically, when the wild-type and ⌬sigB strains were inoculated separately into individual animals, the ⌬sigB strain was found to be impaired in its ability to spread to murine liver and spleen (23) . In this report, we describe the application of a competitive-index method (1), which is designed to control for multiple experimental variables, including interanimal variability (23) , to sensitively assess virulence differences between bacterial strains. For competitive-index studies, equal numbers of two different strains, one of which must bear a selectable marker, are inoculated into the same animal, and then both strains are enumerated at multiple postinfection time points (1) . To ensure that the presence of the selectable marker does not confer a competitive advantage or disadvantage, a control mixture, which is comprised of the strain bearing the marker and an otherwise isogenic strain lacking the marker, is tested in parallel.
The relative virulence of a ⌬sigB null mutant was determined using a competitive-index strategy in a murine model of listeriosis as described by Auerbuch et al. (1) (2 or  4 days), and organ tested (liver or spleen), which enabled us to control for the coordinate effects of these variables. Log 10 CFU/g recovered from mouse livers and spleens at 2 or 4 days postinfection is shown in Table 2 . Higher numbers of the wild-type Erm r DP-L3903 than of the ⌬sigB strain were recovered from the livers (P ϭ 0.109) and spleens (P ϭ 0.013) of i.p.-infected animals after 4 days. When the data were analyzed using the competitive-index strategy, the index generated for bacteria recovered after 4 days from the spleens of mice that had been infected i.p. with the test mixture (Erm s ⌬sigB mutant and Erm r DP-L3903) was higher than the index for the corresponding mice infected with the control mixture; this difference was statistically significant (Table 3) . There was a similar trend in the indices from the livers of i.p.-infected mice, although it was not statistically significant. In summary, the results from the index analyses demonstrate that the ⌬sigB strain is slightly impaired in its ability to spread to the murine spleen following i.p. infection, further supporting the hypothesis that B -regulated gene expression contributes to infection and virulence at specific temporal and spatial points during host-agent interactions.
B contributes to PrfA-directed virulence in vitro. Expression of the majority of recognized virulence genes in L. monocytogenes is regulated by the positive regulatory factor A protein (PrfA) (7, 11) . PrfA is a DNA binding protein that recognizes a 14-bp palindrome in the promoter region of the virulence genes under its control (11) . Previous studies have revealed that prfA transcription can be directed by three promoters: prfAp 1 and prfAp 2 , which are located immediately upstream of prfA, as well as the upstream plcA promoter, which directs expression of a plcA-prfA read-through transcript ( Fig.  1) (12) . We hypothesized that B contributes to virulence gene expression through direction of transcription at the prfAp 2 promoter, which we proposed to be B dependent, based on prfAp 2 's sequence similarity to known B -dependent promoters. Compared with known B -dependent promoters, the prfAp 2 sequence, 5Ј TTGTTACT-N 14 -GGGTAT 3Ј (GenBank accession no. AJ002742), was found to strongly resemble the consensus sequences for the Ϫ35 and Ϫ10 regions of Bdependent promoters identified in B. subtilis (19) , B. anthracis (10), S. aureus (13) , and L. monocytogenes (2, 23) . Previous studies had shown that deletion of either prfAp 1 or prfAp 2 affected in vitro expression of PrfA-regulated genes (12) . Unexpectedly, in spite of these in vitro observations, strains with deletions in either promoter were fully virulent in vivo. Deletion of both P1 and P2, however, resulted in significant virulence attenuation (12) . Based on these observations, we predicted that the phenotype of a ⌬sigB ⌬prfAp 1 double mutant should be identical to that of a ⌬prfAp 1 ⌬prfAp 2 double mutant if prfAp 2 is indeed activated in a B -dependent fashion. Therefore, we constructed a ⌬sigB ⌬prfAp 1 double mutant (FSL B2-002 [ Table 1 ]) to evaluate the functional importance of B -dependent transcription from the prfAp 2 promoter. The ⌬sigB ⌬prfAp 1 double mutant strain was created by allelicexchange mutagenesis following introduction of the Escherichia coli-L. monocytogenes shuttle vector pTJA57 (pKSV7 bearing sigB with an internal deletion [23] ) into DP-L1956 (⌬prfAp 1 ). Electroporation and allelic exchange were done as previously described (6) .
To examine specific B contributions to PrfA-mediated virulence, the relative characteristics of L. monocytogenes strains 10403S, FSL A1-254 (⌬sigB), DP-L1956 (⌬prfAp 1 ), DP-L1957 (⌬prfAp 2 ), DP-L1964 (⌬prfAp 1 ⌬prfAp 2 ), and FSL B2-002 (⌬sigB ⌬prfAp 1 ) (Table 1) were assessed by (i) plaque assays in mouse L cells, (ii) an intracellular-growth assay in mouse macrophage-like J774 cells, and (iii) an in vitro hemolysis assay. The mouse L-cell plaque assay was performed as previously described (22) to evaluate the intracellular-spreading capabilities of the different strains. Briefly, L. monocytogenes 10403S, DP-L1956 (⌬prfAp 1 ), DP-L1957 (⌬prfAp 2 ), DP-L1964 (⌬prfAp 1 ⌬prfAp 2 ), and FSL B2-002 (⌬sigB ⌬prfAp 1 ) were grown overnight at 30°C (without shaking) and inoculated at approximately 3 ϫ 10 4 CFU per well onto a monolayer of mouse L cells grown in six-well plates. The inocula were enumerated by plating serial dilutions on BHI agar. Plaque sizes were measured and expressed relative to the plaque size of the wild-type 10403S strain, which was assigned a plaque size of 100%. As had been reported previously for the ⌬prfAp 1 ⌬prfAp 2 double mutant (12), in our experiments, both double mutants (⌬prfAp 1 ⌬prfAp 2 and ⌬sigB ⌬prfAp 1 ) produced some plaques that were similar in size to those observed for the wild-type 10403S strain, while others were substantially smaller (data not shown). In contrast, all control strains (wild-type 10403S, ⌬sigB, ⌬prfAp 1 , and ⌬prfAp 2 ) showed uniform plaques of similar size. The average plaque sizes for the ⌬prfAp 1 ⌬prfAp 2 double mutant and the ⌬sigB ⌬prfAp 1 double mutant were substantially smaller (67 and 76%, respectively; average of four independent experiments) than the plaques formed by the wild-type parent strain, 10403S (100%). The plaque size was approximately 91% of the wild type for either single mutant (average of four independent experiments).
The intracellular-growth assay was conducted as described previously (20) . Both double mutants (⌬sigB ⌬prfAp 1 and ⌬prfAp 1 ⌬prfAp 2 ) showed delayed intracellular growth compared to the wild-type parent strain, 10403S, and the ⌬prfAp 1 and ⌬prfAp 2 strains (Fig. 2) . Specifically, although equal numbers of each strain had been introduced at the initiation of infection, the intracellular numbers of both double mutants were lower than those observed for the wild type and both single mutant strains at 4 h postinfection and throughout the remaining 24 h. The ⌬prfAp 2 mutant demonstrated the same intracellular growth and spread as wild-type 10403S, while the L. monocytogenes ⌬prfAp 1 mutant showed slight attenuation (Fig. 2) . The results from both the intracellular-growth assay (Fig. 2) and the mouse L-cell plaque assay showed that loss of B function (⌬sigB) combined with a deletion in the Ϫ10 region of prfAp 1 resulted in a striking temporally associated reduction in virulence, identical to the phenotype found when both prfAp 1 and prfAp 2 were deleted.
Hemolytic activity was assayed as previously described (20) using overnight cultures of L. monocytogenes 10403S, DP-L1956 (⌬prfAp 1 ), DP-L1957 (⌬prfAp 2 ), DP-L1964 (⌬prfAp 1 ⌬prfAp 2 ), and FSL B2-002 (⌬sigB ⌬prfAp 1 ). The results were reported as percent hemolysis relative to the wild type. Specifically, data were normalized to the hemolytic activity of strain 10403S, which was assigned a value of 100%. Hemolytic activities for the ⌬sigB and ⌬prfAp 2 mutants were very similar to those of the wild-type strain, whereas the ⌬prfAp 1 mutant showed a nearly threefold reduction in hemolytic activity compared to the wild type (Table 4) , which is also consistent with the intracellular growth attenuation phenotype displayed by the ⌬prfAp 1 strain (Fig. 2) . As with the ⌬prfAp 1 ⌬prfAp 2 double mutant, the ⌬sigB ⌬prfAp 1 double mutant showed no hemolytic activity (Table 4) . Our hypothesis that loss of B activity has the same effect as deletion of prfAp 2 is supported by the fact that the phenotype of our ⌬sigB ⌬prfAp 1 double mutant resembles that of the previously described ⌬prfAp 1 ⌬prfAp 2 double mutant (12) .
We conclude that the P2 promoter of prfA is indeed B dependent and that B directly contributes to virulence via regulation of prfA expression. This conclusion is consistent with the previous observation that expression of some PrfAdependent proteins, including ActA, is induced under stress conditions, such as heat shock or entry into stationary phase (21) . In parallel, L. monocytogenes B activity also increases following exposure of cells to heat and upon entry into stationary phase (2). Our discovery that prfAp 2 is a bona fide Bdependent promoter extends the work of Freitag and Portnoy, who showed that although elimination of either prfAp 1 or prfAp 2 affected in vitro expression of PrfA-regulated genes, strains with either of these mutations remained fully virulent in vivo (12) . Expression of a global virulence gene regulator under the direction of multiple sigma factors (e.g., A and B ) may help to ensure that virulence factors are efficiently transcribed as needed under a wide variety of in vivo environmental conditions. Thus, loss of either the A -dependent prfAp 1 or the B -dependent prfAp 2 promoter may result in only subtle virulence defects that may be undetectable in commonly used animal models. 
